Cameron O G, Smith C B, Hollingsworth P J, Nesse R M, Curtis G C
Arch Gen Psychiatry. 1984 Dec;41(12):1144-8. doi: 10.1001/archpsyc.1984.01790230030004.
Specific binding of tritiated clonidine, an alpha 2-adrenergic receptor agonist, and tritiated yohimbine, an alpha 2-adrenergic receptor antagonist, to platelet membranes was measured in persons with panic attacks or major depression and in normal subjects. Plasma catecholamine levels were measured in patients with panic attacks and in normal subjects. The number of binding sites in patients with panic attacks, as measured with tritiated clonidine, was lower than in depressed persons and was the same as in normal subjects. The number in patients with panic attacks, as measured with tritiated yohimbine, was lower than in either depressives or normal subjects. Catecholamine levels were somewhat higher in patients with panic attacks than in normal subjects. Treatment with imipramine hydrochloride decreased the number of sites, as measured with either ligand, in both patient groups and increased catecholamine levels in patients with panic attacks.
在恐慌症或重度抑郁症患者以及正常受试者中,测量了α2 - 肾上腺素能受体激动剂氚标记可乐定和α2 - 肾上腺素能受体拮抗剂氚标记育亨宾与血小板膜的特异性结合。在恐慌症患者和正常受试者中测量了血浆儿茶酚胺水平。用氚标记可乐定测量时,恐慌症患者的结合位点数量低于抑郁症患者,与正常受试者相同。用氚标记育亨宾测量时,恐慌症患者的结合位点数量低于抑郁症患者和正常受试者。恐慌症患者的儿茶酚胺水平略高于正常受试者。盐酸丙咪嗪治疗使两组患者中用任一配体测量的位点数量减少,并使恐慌症患者的儿茶酚胺水平升高。